19A Antibodies for Diagnosis of Acute Congenital and Acquired Toxoplasmosis
Pamela Stepick-Biek, Philippe Thulliez, Fausto G. Araujo, and Jack S. Remington An ELISA for IgA toxoplasma antibodies was positive in 12 pregnant women who seroconverted during gestation. Positive IgA titers were also noted in 10 individuals with biopsy-proven toxoplasmic lymphadenitis; the highest titers were noted in the first months following onset of clinical signs. Toxoplasma IgA antibodies were also demonstrable in 8 of 9 infants/fetuses with congenital toxoplasma infection. In some, IgM antibodies could not be demonstrated. Among 20 patients with AIDS and biopsy-proven toxoplasmic encephalitis, only 1 had IgA antibodies. None of20 individuals with chronic toxoplasma infection had demonstrable IgA antibodies. Demonstration of IgA toxoplasma antibodies should be useful for diagnosis of recently acquired infection and for diagnosis of the infection in the fetus and newborn.
Interpretation of currently available serologic methods for the definitive diagnosis of early acute infection with Toxoplasma gondii in adults is complicated by the prevalence of high IgG Toxoplasma antibody titers among normal individuals in most populations [1] and the fact that IgM antibodies may, in some individuals, persist for months or even years following acute infection [2] . Although interpretation of serologic tests for diagnosis of congenital infection is usually less complicated, there is great need for newer methods with higher specificity and sensitivity. Thus, there is a continued search for additional techniques which, when used alone or in combination with presently available tests, will allow for early diagnosis of the acute infection in adults and of congenital infection in the fetus and newborn.
The presence of IgA antibodies to T. gondii in humans has been reported by investigators who used a variety of methods for their detection [3] [4] [5] [6] [7] . Some investigators considered the finding of specific IgA antibodies to be of little importance for diagnosis of the acute stage of the infection [3, 5] whereas others considered it useful [6, 7] . These apparently contrasting conclusions led us to examine whether detection of T. gondii IgA antibodies would be useful for diagnosis in different clinical situations.
Materials and Methods
Serum samples. Serum samples were obtained from five groups.
gestation [1] . The sample obtained just before the one in which seroconversion occurred is called the preconversion sample. The serum in which seroconversion was documented is referred to as the conversion sample. Group B patients with toxoplasmic lymphadenopathy were diagnosed by both lymph node biopsy [8] and serologic test tiers [2] . Group C patients had acquired immunodeficiency syndrome (AIDS) and biopsy-proven toxoplasmic encephalitis [9] .
Group D comprised infants with congenital Toxoplasma infection diagnosed by isolation of the parasite from blood and/or amniotic fluid [1] . Group E included adults without clinical disease who were known to be seropositive for Toxoplasma antibodies~2 years before serum samples were drawn for this study. The sera from each patient in the five groups were run in parallel in each of the serologic tests.
Serologic tests. The Sabin-Feldman dye test, IgM ELISA, direct agglutination test, and IgM immunosorbent assay (IgM ISAGA) were performed and their titers reported as previously described [1, 2] . The IgA ELISA was performed as described by Santoro et al. [10] , with slight modifications, and similar to the IgM ELISA described by Naot et al. [11] . (There were no significant differences in titers obtained with these two methods.) Briefly, affinity-purified goat anti-human IgA (Caltag, South San Francisco, CA) was diluted in 0.05 M carbonate buffer to 10 Ilg/ml, a concentration found to be optimal in preliminary experiments, then 100 or 175 III was pipetted into wells of polystyrene microtiter plates (NUNC, Roskilde, Denmark), and incubated at 4°C overnight. Thereafter, wells were washed three times with phosphate-buffered saline (PBS) containing 0.05% Tween 20 (PBS-Tween). To each well, 200 III of 0.1% gelatin containing 0.5 % Tween 20 in PBS (gelatin-PBS-Tween) was added to each well, and the plates wete incubated 2 h at room temperature or for 2 h at 37°C. Three additional washes were followed by addition of 100 or 175 IIIper well of the serum samples diluted 1:50 in gelatin-PBS-Tween. Each sample was examined in triplicate. The plates were incubated for 1 or 2 h at 3rC, and the wells were again washed three times with PBS-Tween. Thereafter, 100 or 175 Ill, containing 100 Ilg/ml antigen (a concentration found optimal in preliminary experiments; antigen was obtained as previously described [11] ), was pipetted into two of the triplicate wells; to the third well 100 or 175 III of only the gelatin-PBS-Tween was added. The plates were then incubated mean (minus the optical density of the well without antigen) of the 1 h at 37°C or overnight at 4°C, washed three times as above, and absorbances of seronegative individuals plus 2 So. The average ab-100 or 175 III of rabbit anti-Toxoplasma F(ab1 2 conjugated to alkasorbance of 41 seronegative adults was 0.034; SD was 0.017. For 10 line phosphatase diluted in gelatin-PBS-Tweenwas added to all wells.
noninfected infants born to mothers who acquired acute toxoplasma The optimum dilution of the conjugate was determined in prelimiinfection during pregnancy, the average absorbance was 0.036 and nary experiments. After incubation for 1 h at 37°C or 3 h at room the SD was 0.015. temperature a final wash with PBS-Tween as above was followed by addition of 100 or 175 III of the substrate solution, ( 
T. gondii.
In a separate study we tested nine uninfected infants born to mothers who seroconverted during gestation. All of the mothers, but none of the infants, had IgA antibodies (data not shown).
None of the 20 adults in Group E with chronic (latent) Ibxoplasma infection had demonstrable IgA or IgM antibodies; all were positive in the dye test with titers of 6-400 IV.
Discussion
Our results revealed the value of the IgA ELISA in pre-and postnatal diagnosis of congenital Toxoplasma infection and confirm and extend those of Decoster et al. [6] , Pinon et al. [7] , and Le Fichoux et al. [12] , who also concluded that demonstration of IgA antibody appears useful for diagnosis of the congenital infection. (We consider it important to test other than cord serum to avoid contamination of the sample with maternal blood. In our experience such contamination is frequent [data not shown]). Our results also revealed the potential usefulness of this method for -the early diagnosis of acute infection in the pregnant patient.
Results obtained in the patients with lymphadenopathic toxoplasmosis revealed higher IgA antibody titers in those serum samples collected early after onset of clinical illness. Because serial samples were not availablein these cases, the value of the test in relation to the IgM ELISA is not known. Since patients with infection >2 years did not have demonstrable IgA antibody, the IgA ELISA, when it is positive, may be useful in lymphadenopathic cases when IgM antibody is not demonstrable [2] .
The results of the IgA test in the AIDS patients with proven toxoplasmic encephalitis were disappointing. None had demonstrable IgA antibodies except for the one patient who also had IgM antibodies. Derouin et al. [13] did not find demonstration of IgA-specific antibodies diagnostic in their AIDS patients with clinical toxoplasmosis.
We consider it important to include IgA antibody determination for screening of pregnant women [14] , for prenatal di-agnosis [15] , and for testing of newborns in whom there is reason to suspect congenital Toxoplasma infection.
